This pharmaceutical stock hits an all-time high: The company expects normal growth in FY25 with a revival in the specialty chemicals industry This pharmaceutical stock hits an all-time high: The company expects normal growth in FY25 with a revival in the specialty chemicals industry The stock hit a fresh all-time high on Friday at Rs 634, and the stock closed at Rs 615 with gains of 0.2 per cent DSIJ Intelligence-2 / Friday, November 24, 2023 0 10011 Article rating: 3.4 Over the past three months, the stock has returned 21.14 per cent. Over the past three years, the stock has returned a staggering 65.79 per cent. Over the past five years, the stock has returned an even more impressive 322.93 per cent. Read more
Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it? Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it? Advent is expected to buy 51 per cent of the promoter’s stake in the company and launch an open offer for an additional 26 per cent DSIJ Intelligence / Monday, December 26, 2022 0 1304 Article rating: 4.3 The company released a press release on Monday, stating Advent International has entered into definitive agreement to acquire significant stake in the company and intends to explore the merger of its portfolio company Read more